Lisa Shulman is director of autism clinical services at the Children’s Evaluation and Rehabilitation Center at Montefiore Medical Center in New York City.
Lisa Shulman
Director of autism clinical services
Children’s Evaluation and Rehabilitation Center, Montefiore Medical Center
From this contributor
How to help underserved groups gain access to autism care
Place your autism center in the community you serve, remove barriers to care, cast a wide net for autism signs, and do as much as possible in the first visit: These principles can help build a lifelong relationship with the community.
How to help underserved groups gain access to autism care
By
Lisa Shulman
15 January 2019 | 6 min read
Children who ‘recover’ from autism still struggle
Some children with autism lose their diagnosis over time, but still struggle with language, learning and anxiety, says Lisa Shulman.
Explore more from The Transmitter
From friend to foe: How the brain updates feelings toward others
A specific hippocampus-to-amygdala pathway reassigns emotional valence to a known individual, whereas the hippocampus’s own representation of that individual’s identity remains stable.
From friend to foe: How the brain updates feelings toward others
A specific hippocampus-to-amygdala pathway reassigns emotional valence to a known individual, whereas the hippocampus’s own representation of that individual’s identity remains stable.
By
Natalia Mesa
9 July 2026 | 5 min read
Mass-produced science is coming. What happens to scientists?
Artificial intelligence may soon enable researchers to generate high-quality science at a previously unimaginable speed. For science consumers—the public, medical patients, technology users—the likely effects will be positive. For scientists, the effects will be as disruptive as industrial mass production was for artisan manufacturers.
Mass-produced science is coming. What happens to scientists?
Artificial intelligence may soon enable researchers to generate high-quality science at a previously unimaginable speed. For science consumers—the public, medical patients, technology users—the likely effects will be positive. For scientists, the effects will be as disruptive as industrial mass production was for artisan manufacturers.
By
Kenneth Harris
9 July 2026 | 9 min read
Neuropathologist not guilty of research misconduct, says university probe
The investigation determined that seven papers by corresponding author Adriano Aguzzi have “scientifically significant” errors, which Aguzzi attributes to his former students.
Neuropathologist not guilty of research misconduct, says university probe
The investigation determined that seven papers by corresponding author Adriano Aguzzi have “scientifically significant” errors, which Aguzzi attributes to his former students.
By
Dalmeet Singh Chawla
8 July 2026 | 5 min read